| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.12 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |